Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Case and Commentary Oct 2008 Physician and Parental Decision Making in Newborn Resuscitation, Commentary 2 Frank A. Chervenak, MD and Laurence B. McCullough, PhD Virtual Mentor. 2008;10(10):620-624. doi: 10.1001/virtualmentor.2008.10.10.ccas1-0810. Case and Commentary Sep 2013 Weighing Risks and Benefits of Prescribing Antidepressants during Pregnancy Benjamin C. Silverman, MD and Anne F. Gross, MD Virtual Mentor. 2013;15(9):746-752. doi: 10.1001/virtualmentor.2013.15.9.ecas1-1309. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.